Extraction of a translocated piece of an implantable cardioverter-defibrillator lead from the hepatic vein by Oręziak, Artur et al.
Address for correspondence: Artur Oręziak, MD, PhD, Department of Arrhythmia, Institute of Cardiology, ul. Alpejska 42, 
04–628 Warszawa, Poland, tel/fax: +48 603374235, +48 22 3434417/+48 22 3434520, e-mail: aoreziak@ikard.pl
Received: 09.04.2018 Accepted: 07.08.2018
Extraction of a translocated piece of  
an implantable cardioverter-defibrillator  
lead from the hepatic vein
Artur Oręziak1, Anna Wojno2, Adam Parulski3, Maciej Sterliński1
1Department of Arrhythmia, Institute of Cardiology, Warsaw, Poland  
2Department of Anesthesiology, Institute of Cardiology, Warsaw, Poland 
3Department of Cardiac Surgery and Transplantology, Institute of Cardiology, Warsaw, Poland
Transvascular lead extraction (TLE) is associ-
ated with technical limitations and complications, 
including fragmentation of the lead body and its 
uncontrolled translocation.
This article reports the case of a 50-year-old 
female with an atrial valve replaced 32 years ago, 
paroxysmal atrial fibrillation, congestive heart 
failure with a 40% ejection fraction, and Epic VR 
(St. Jude Medical, USA) implantable cardioverter-
defibrillator (ICD) with a Linox S 65 single-coil 
active defibrillation lead (Biotronik, Germany) im-
planted in 2009. She was referred for TLE because 
of damage to the defibrillation lead. 
During TLE, the defibrillation lead insulation 
was pulled out below the inserted Liberator lock-
ing stylet (Cook Medical, USA), stretching the 
coil-wire and leaving the distal part of the lead 
(Fig. 1A). Attempts to remove the remains of the 
lead through femoral access using a Needle’s Eye 
Snare (Cook Medical, USA) were unsuccessful — 
the coil-wire was torn and a loose fragment trans-
located to the hepatic vein (Fig. 1B). The broken 
lead fragment was successfully removed using 
a bioptome (Jawz™ Endomyocardial Biopsy For-
ceps, Argon Medical Devices, USA) which was 
inserted through the transseptal Agilis™ NxT 
steerable introducer (SJM, USA) placed in the 
hepatic vein (Fig. 1C, Suppl. Video 1).
Fragmented parts of extracted leads may 
be a source of venous embolism. The real clini-
cal significance of a small metallic wire left in the 
hepatic vein is still unknown with respect to po-
tential infectious and mechanical consequences, 
but it was shown that the decision to remove the 
wire from the hepatic vein was effective and safe 
(Fig. 1D). 
Conflict of interest: Artur Oręziak — fees 
from St. Jude Medical, Medtronic and Biotronik; 
Maciej Sterliński — fees from Hammermed (Cook), 
Medtronic, St. Jude Medical and Biotronik; Anna 
Wojno and Adam Parulski — none declared.
745www.cardiologyjournal.org
INTERVENTIONAL CARDIOLOGY
Cardiology Journal 
2018, Vol. 25, No. 6, 745–746 
DOI: 10.5603/CJ.2018.0150 
Copyright © 2018 Via Medica
ISSN 1897–5593IMAGE IN CARDIOVASCULAR MEDICINE
Figure 1. A. The stretched coil-wire during transvascular lead extraction of the defibrillation lead (right anterior oblique 
view [RAO] 25o); B. Venography of the hepatic veins with the translocated fragment of the metal coil-wire (RAO 25o); 
C. Removal of the fragment of the metal coil-wire from the hepatic vein using the bioptome in the steerable introducer 
(RAO 25o); D. Venogram of the hepatic veins after removal of the part of metal coil-wire (RAO 25o).
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